Diabetes abolishes ischemic preconditioning: role of glucose, insulin, and osmolality

被引:184
作者
Kersten, JR
Toller, WG
Gross, ER
Pagel, PS
Warltier, DC
机构
[1] Med Coll Wisconsin, Dept Anesthesiol, Div Cardiovasc Dis, Milwaukee, WI 53226 USA
[2] Med Coll Wisconsin, Dept Pharmacol, Milwaukee, WI 53226 USA
[3] Med Coll Wisconsin, Dept Med, Milwaukee, WI 53226 USA
[4] Zablocki Vet Affairs Med Ctr, Milwaukee, WI 53226 USA
来源
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY | 2000年 / 278卷 / 04期
关键词
diabetes mellitus; myocardial infarction;
D O I
10.1152/ajpheart.2000.278.4.H1218
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Recent evidence indicates that hyperglycemia is an important risk factor for the development of cardiovascular disease. We tested the hypothesis that myocardial infarct size is related to blood glucose concentration in the presence or absence of ischemic preconditioning (PC) stimuli in canine models of diabetes mellitus and acute hyperglycemia. Barbiturate-anesthetized dogs were subjected to a 60-min period of coronary artery occlusion and 3-h reperfusion. Infarct size was 24 +/- 2% of the area at risk (AAR) for infarction in control dogs. PC significantly (P < 0.05) decreased the extent of infarction in normal(8 +/- 2% of AAR), but not diabetic (22 +/- 4% of AAR), dogs. Infarct size was linearly related to blood glucose concentration during acute hyperglycemia (r = 0.96; P < 0.001) and during diabetes (r = 0.74; P < 0.002) in the presence or absence of PC stimuli. Increases in serum osmolality caused by administration of raffinose (300 g) did not increase infarct size (11 +/- 3% of AAR) or interfere with the ability of PC to protect against infarction (2 +/- 1% of AAR). The results indicate that hyperglycemia is a major determinant of the extent of myocardial infarction in the dog.
引用
收藏
页码:H1218 / H1224
页数:7
相关论文
共 34 条
  • [11] Improved myocardial tolerance to ischaemia in the diabetic rabbit
    Hadour, G
    Ferrera, R
    Sebbag, L
    Forrat, R
    Delaye, J
    de Lorgeril, M
    [J]. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1998, 30 (09) : 1869 - 1875
  • [12] *INT COLL GROUP, 1979, J CHRON DIS, V32, P829
  • [13] Outcomes of diabetic patients following acute myocardial infarction: A review of the major thrombolytic trials
    Jelesoff, NE
    Feinglos, M
    Granger, CB
    Califf, RM
    [J]. CORONARY ARTERY DISEASE, 1996, 7 (10) : 732 - 743
  • [14] IMPAIRED MICROVASCULAR RESPONSE TO GRADED CORONARY-OCCLUSION IN DIABETIC AND HYPERGLYCEMIC DOGS
    KERSTEN, JR
    BROOKS, LA
    DELLSPERGER, KC
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1995, 268 (04): : H1667 - H1674
  • [15] Acute hyperglycemia abolishes ischemic preconditioning in vivo
    Kersten, JR
    Schmeling, TJ
    Orth, KG
    Pagel, PS
    Warltier, DC
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1998, 275 (02): : H721 - H725
  • [16] Mechanism of myocardial protection by isoflurane - Role of adenosine triphosphate-regulated potassium (K-ATP) channels
    Kersten, JR
    Schmeling, TJ
    Hettrick, DA
    Pagel, PS
    Gross, GJ
    Warltier, DC
    [J]. ANESTHESIOLOGY, 1996, 85 (04) : 794 - 807
  • [17] Isoflurane mimics ischemic preconditioning via activation of K-ATP channel - Reduction of myocardial infarct size with an acute memory phase
    Kersten, JR
    Schmeling, TJ
    Pagel, PS
    Gross, GJ
    Warltier, DC
    [J]. ANESTHESIOLOGY, 1997, 87 (02) : 361 - 370
  • [18] KIRSCH GE, 1990, AM J PHYSIOL, V259, P820
  • [19] Koltai MZ, 1997, CARDIOVASC RES, V34, P157
  • [20] Hyperglycemia and cardiovascular disease in Type 2 diabetes
    Laakso, M
    [J]. DIABETES, 1999, 48 (05) : 937 - 942